5-HT2A Agonist Psilocybin in the Treatment of Addiction
This summary needs review. Please check the official study record and contact the research team for details.
In BirminghamThis study is directly about Addiction.
Get research updatesCompare studies and check their requirements with the research team.
This summary needs review. Please check the official study record and contact the research team for details.
In BirminghamThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
In CharlestonThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
In BirminghamThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
In New YorkThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
In AuburnThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
In SeattleThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including New HavenThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
In JohannesburgThis study is directly about Addiction.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including GreenvilleThis study is directly about Addiction.
The registry lists this study as recruiting. Study locations are listed in the United States.
In AlbuquerqueThis study is directly about Addiction.
The registry describes this research topic: “A pilot study of the pharmacokinetics, efficacy, and acceptability of a novel nicotine inhaler in smokers”. This is an interventional study.
In New ZealandThis study is directly about Addiction.
The registry lists this study as recruiting. Study locations are listed in Australia.
In SydneyThis study is directly about Addiction.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.